Martin Olav Sabo Quotes

Congress has a responsibility to review research paid for by hard-working American taxpayers.

My efforts to join the fight against breast cancer all began around the fact that women were getting short-changed in the medical arena.

Hard as it is to imagine, there's a move afoot in Congress to take away the public's free online access to tax-funded medical research findings. That would be bad for medical discovery, bad for patients looking for the latest research results, and another rip-off of the American taxpayer.

Reducing the price of cancer drugs is a humanitarian move.

Over the years, HIV/AIDS activists and their allies have been pioneers in creating new frontiers in the medical establishment. Through their efforts, the FDA drug approval procedures were reformed so promising new therapies could reach desperate patients quicker.

When people affected by epilepsy are reluctant to expose their condition, the public remains in the dark about it - a tragic irony that has made patient care and raising funds for research more than challenging.

I have profoundly mixed feelings about the Affordable Care Act. What I love about it is its impulse. It attempts to deal with this intractable problem in American health care life, which is that a significant portion of the population does not have access to quality medical care.

What do we have for veterans? Government-run health care. I understand that. Congressmen and senators... they get five choices of government-run health care. Why should a congressman and senator get anything more than a regular citizen does? Why are they privileged and the rest of us aren't?

I think it's scandalous that we haven't done more to cure cancer.

My mother has battled breast cancer three times.

The national debate on health care once centered on improving access to quality care, yet the effect of Obamacare will be the exact opposite, resulting in the shameful degradation of care for the neediest individuals.

Innovations in science and technology are the engines of the 21st-century economy; if you care about the wealth and health of your nation tomorrow, then you'd better rethink how you allocate taxes to fund science. The federal budget needs to recognize this.

Dedicated researchers seek better treatments and cures for diabetes, kidney disease, Alzheimer's and every form of cancer. But these scientists face an array of disincentives. We can do better.

Let's make health care a meritocracy. Access to the best care goes to people who did what they could to avoid becoming ill.

And I'll tell you, honestly, folks that I talk to, the 2.5 million breast cancer survivors in America, that I am one of, understand that we're done with insurance companies dropping us or denying us coverage because of - because we have a preexisting condition.

We can't get to the $4 trillion in savings that we need by just cutting the 12 percent of the budget that pays for things like medical research and education funding and food inspectors and the weather service. And we can't just do it by making seniors pay more for Medicare.

The reason I ran in 2006 was to make my district one of the fifteen that at the time it would have taken to switch the control of the House and stop the Bush agenda. The second priority I had was to provide health care for everybody. And the third was to do public financing of campaigns.

I think history would say that medical research has, throughout many changes of parties, remained as one of the shining lights of bipartisan agreement, that people are concerned about health for themselves, for their families, for their constituents.

Embryonic stem cell research is a key that will unlock the future.

This is using taxpayer money to pay for the intentional destruction of human life

Cost containment too often becomes care containment. And it affects the least powerful population sector with the quietest voice.

Is paving asphalt more important than cancer research.

Cancer Doesn’t Care How Busy You Are. Make an appointment!

NIH has become the Beirut of abortion and fetal tissue research.

It’s our tax dollars that fund the initial research for these molecules that get transferred to corporations. We have an investment here… We end up paying for our drugs twice. We pay for the initial development through our tax dollars. And then when it goes on the market we pay their inflated prices.